ALVO (Alvotech S.A.) Net Profit

Corporate emblem and logo of alvotech.com (ALVO)

Stable cash flow from the sale of complex drug analogs creates a reliable financial foundation for Alvotech. Alvotech focuses on producing biosimilars, rapidly capturing niches following the patent expiration of market leaders. Its own high-tech plant in Iceland ensures full control over product quality. The company's final net income on this chart clearly demonstrates the results, where the -0.18 indicator reflects the current trend.

ALVO (Alvotech SA) Company Net Income history from 04/28/2023 to 10/29/2026

Financial and market metric breakdowns for Alvotech SA (ALVO)

- price and consensus price forecast:
Stock Quotes Alvotech Biopharmaceuticals|ALVO - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Alvotech Biopharmaceuticals|ALVO - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Alvotech|ALVO - Company Book Value|Market-to-Book Ratio alvotech.com|ALVO - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Alvotech|ALVO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Alvotech S.A.|ALVO - Company Aggregate Debts|Debts to Book Value Alvotech Biopharmaceuticals|ALVO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Alvotech|Quick Ratio alvotech.com
- net income and valuation multiples indicators:
ALVO - Company Net Income
Fundamental valuation:ALVO Alvotech Biopharmaceuticals
Flagship merchandise of Alvotech S.A.

Alvotech's specific positioning within the biopharmaceutical sector is exposed to risks from cross-border patent disputes and logistical disruptions, which directly impact operational efficiency. Analyzing the company's profit margins, an investor observes daily revenue consolidation that reveals hidden quarterly drawdowns and assesses business resilience to geopolitical barriers through the stability of the financial corridor on this chart.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|LQDA: Net Income|glpg.com - Profit After Payment of Taxes|ANIP: Net Profit|MannKind Corp - Final Profit|AMPH (Amphastar) - Net Profit|Company Net Income Pacira Corp PCRX|Company Net Income ARS Pharmaceuticals (SPRY)|TBPH (theravance.com) - Final Profit|Net Profit AQST (Aquestive Therapeutics, Inc.)|Net Profit scPharmaceuticals, Inc. SCPH|TECX - Company Net Income|TNXP: Company Net Income|SXTC (sxtchina.com) - Net Income|EPRX (Eupraxia Pharmaceuticals Inc.) - Company Net Income|Company Net Income BioHarvest Sciences Inc.|Company Net Income Invizyne Technologies EXOZ|Net Income ORMP (Oramed Pharmaceuticals)|Profit After Payment of Taxes ENTX|Net Profit HYFT (MindWalk Holdings)|abvcpharma.com (ABVC) - Company Net Income|Cumberland Pharmaceuticals Inc. - Net Profit|Quantum BioPharma Ltd. (QNTM) - Net Income|FGEN: Net Profit|Telomir Pharmaceuticals Corp - Final Profit|RANI (Rani Therapeutics Holdings) - Net Profit|Net Profit Synergy CHC Corporation|Company Net Income Rallybio Corporation (RLYB)|Company Net Income LEXX (lexariabioscience.com)|Pulmatrix Corp - Net Income|Pheton Holdings Limited - Company Net Income|APM - Company Net Income|Company Net Income lyratherapeutics.com|Impact BioMedical Inc (IBO) - Company Net Income|Profit After Tax TNFA (TNF Pharmaceuticals, Inc.)|YCBD (cbdMD Inc.) - Net Profit|PRFX: Final Profit|Net Profit CYTO|Net Profit lipella.com (LIPO)|Company Net Income OptiNose OPTN|Final Profit PIRS|PROC - Company Net Income|Petros Pharma (PTPI) - Net Income|QLI: Net Profit|acelyrin.com (SLRN) - Net Profit|Net Income TFFP